0
     

Report Added
Report already added
Ankylosing Spondylitis Drug Market - Global Outlook and Forecast 2022-2028

Ankylosing Spondylitis Drug Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Ankylosing Spondylitis Drug in Global, including the following market information:

Global Ankylosing Spondylitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ankylosing Spondylitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cimzia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ankylosing Spondylitis Drug include Amgen, Wyeth, Takeda, Centocor, Schering-Plough, Mitsubishi Tanabe, Abbott, Eisai and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ankylosing Spondylitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Ankylosing Spondylitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ankylosing Spondylitis Drug Market Segment Percentages, by Type, 2021 (%)
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Global Ankylosing Spondylitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ankylosing Spondylitis Drug Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Ankylosing Spondylitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ankylosing Spondylitis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ankylosing Spondylitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ankylosing Spondylitis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Ankylosing Spondylitis Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ankylosing Spondylitis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ankylosing Spondylitis Drug Overall Market Size
2.1 Global Ankylosing Spondylitis Drug Market Size: 2021 VS 2028
2.2 Global Ankylosing Spondylitis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ankylosing Spondylitis Drug Players in Global Market
3.2 Top Global Ankylosing Spondylitis Drug Companies Ranked by Revenue
3.3 Global Ankylosing Spondylitis Drug Revenue by Companies
3.4 Top 3 and Top 5 Ankylosing Spondylitis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ankylosing Spondylitis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ankylosing Spondylitis Drug Players in Global Market
3.6.1 List of Global Tier 1 Ankylosing Spondylitis Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Ankylosing Spondylitis Drug Market Size Markets, 2021 & 2028
4.1.2 Cimzia
4.1.3 Enbrel
4.1.4 Humira
4.1.5 Remicade
4.1.6 Simponi
4.1.7 Others
4.2 By Type - Global Ankylosing Spondylitis Drug Revenue & Forecasts
4.2.1 By Type - Global Ankylosing Spondylitis Drug Revenue, 2017-2022
4.2.2 By Type - Global Ankylosing Spondylitis Drug Revenue, 2023-2028
4.2.3 By Type - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ankylosing Spondylitis Drug Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Ankylosing Spondylitis Drug Revenue & Forecasts
5.2.1 By Application - Global Ankylosing Spondylitis Drug Revenue, 2017-2022
5.2.2 By Application - Global Ankylosing Spondylitis Drug Revenue, 2023-2028
5.2.3 By Application - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Ankylosing Spondylitis Drug Market Size, 2021 & 2028
6.2 By Region - Global Ankylosing Spondylitis Drug Revenue & Forecasts
6.2.1 By Region - Global Ankylosing Spondylitis Drug Revenue, 2017-2022
6.2.2 By Region - Global Ankylosing Spondylitis Drug Revenue, 2023-2028
6.2.3 By Region - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Ankylosing Spondylitis Drug Revenue, 2017-2028
6.3.2 US Ankylosing Spondylitis Drug Market Size, 2017-2028
6.3.3 Canada Ankylosing Spondylitis Drug Market Size, 2017-2028
6.3.4 Mexico Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Ankylosing Spondylitis Drug Revenue, 2017-2028
6.4.2 Germany Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.3 France Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.4 U.K. Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.5 Italy Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.6 Russia Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.7 Nordic Countries Ankylosing Spondylitis Drug Market Size, 2017-2028
6.4.8 Benelux Ankylosing Spondylitis Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Ankylosing Spondylitis Drug Revenue, 2017-2028
6.5.2 China Ankylosing Spondylitis Drug Market Size, 2017-2028
6.5.3 Japan Ankylosing Spondylitis Drug Market Size, 2017-2028
6.5.4 South Korea Ankylosing Spondylitis Drug Market Size, 2017-2028
6.5.5 Southeast Asia Ankylosing Spondylitis Drug Market Size, 2017-2028
6.5.6 India Ankylosing Spondylitis Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Ankylosing Spondylitis Drug Revenue, 2017-2028
6.6.2 Brazil Ankylosing Spondylitis Drug Market Size, 2017-2028
6.6.3 Argentina Ankylosing Spondylitis Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ankylosing Spondylitis Drug Revenue, 2017-2028
6.7.2 Turkey Ankylosing Spondylitis Drug Market Size, 2017-2028
6.7.3 Israel Ankylosing Spondylitis Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Ankylosing Spondylitis Drug Market Size, 2017-2028
6.7.5 UAE Ankylosing Spondylitis Drug Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Ankylosing Spondylitis Drug Major Product Offerings
7.1.4 Amgen Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Wyeth
7.2.1 Wyeth Corporate Summary
7.2.2 Wyeth Business Overview
7.2.3 Wyeth Ankylosing Spondylitis Drug Major Product Offerings
7.2.4 Wyeth Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.2.5 Wyeth Key News
7.3 Takeda
7.3.1 Takeda Corporate Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Ankylosing Spondylitis Drug Major Product Offerings
7.3.4 Takeda Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.3.5 Takeda Key News
7.4 Centocor
7.4.1 Centocor Corporate Summary
7.4.2 Centocor Business Overview
7.4.3 Centocor Ankylosing Spondylitis Drug Major Product Offerings
7.4.4 Centocor Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.4.5 Centocor Key News
7.5 Schering-Plough
7.5.1 Schering-Plough Corporate Summary
7.5.2 Schering-Plough Business Overview
7.5.3 Schering-Plough Ankylosing Spondylitis Drug Major Product Offerings
7.5.4 Schering-Plough Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.5.5 Schering-Plough Key News
7.6 Mitsubishi Tanabe
7.6.1 Mitsubishi Tanabe Corporate Summary
7.6.2 Mitsubishi Tanabe Business Overview
7.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Major Product Offerings
7.6.4 Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.6.5 Mitsubishi Tanabe Key News
7.7 Abbott
7.7.1 Abbott Corporate Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Ankylosing Spondylitis Drug Major Product Offerings
7.7.4 Abbott Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.7.5 Abbott Key News
7.8 Eisai
7.8.1 Eisai Corporate Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Ankylosing Spondylitis Drug Major Product Offerings
7.8.4 Eisai Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.8.5 Eisai Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Ankylosing Spondylitis Drug Major Product Offerings
7.9.4 Pfizer Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Major Product Offerings
7.10.4 Johnson & Johnson Ankylosing Spondylitis Drug Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Ankylosing Spondylitis Drug Market Opportunities & Trends in Global Market
Table 2. Ankylosing Spondylitis Drug Market Drivers in Global Market
Table 3. Ankylosing Spondylitis Drug Market Restraints in Global Market
Table 4. Key Players of Ankylosing Spondylitis Drug in Global Market
Table 5. Top Ankylosing Spondylitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ankylosing Spondylitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ankylosing Spondylitis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ankylosing Spondylitis Drug Product Type
Table 9. List of Global Tier 1 Ankylosing Spondylitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ankylosing Spondylitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ankylosing Spondylitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ankylosing Spondylitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ankylosing Spondylitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ankylosing Spondylitis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ankylosing Spondylitis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Ankylosing Spondylitis Drug Product Offerings
Table 32. Amgen Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Wyeth Corporate Summary
Table 34. Wyeth Ankylosing Spondylitis Drug Product Offerings
Table 35. Wyeth Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Ankylosing Spondylitis Drug Product Offerings
Table 38. Takeda Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Centocor Corporate Summary
Table 40. Centocor Ankylosing Spondylitis Drug Product Offerings
Table 41. Centocor Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Schering-Plough Corporate Summary
Table 43. Schering-Plough Ankylosing Spondylitis Drug Product Offerings
Table 44. Schering-Plough Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Mitsubishi Tanabe Corporate Summary
Table 46. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Offerings
Table 47. Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Corporate Summary
Table 49. Abbott Ankylosing Spondylitis Drug Product Offerings
Table 50. Abbott Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Eisai Corporate Summary
Table 52. Eisai Ankylosing Spondylitis Drug Product Offerings
Table 53. Eisai Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Ankylosing Spondylitis Drug Product Offerings
Table 56. Pfizer Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Ankylosing Spondylitis Drug Product Offerings
Table 59. Johnson & Johnson Ankylosing Spondylitis Drug Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Ankylosing Spondylitis Drug Segment by Type in 2021
Figure 2. Ankylosing Spondylitis Drug Segment by Application in 2021
Figure 3. Global Ankylosing Spondylitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ankylosing Spondylitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ankylosing Spondylitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2021
Figure 8. By Type - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 12. US Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 24. China Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ankylosing Spondylitis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ankylosing Spondylitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Wyeth Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Centocor Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Schering-Plough Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eisai Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Ankylosing Spondylitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Ankylosing Spondylitis Drug Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Bispecific Antibody Market Opportunity, Drug Sales, Price  & Clinical Trials Insight 2028

Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

AI for Drug Discovery Market By Offering (Software, Services);By Technology (Machine Learning and Other Technologies); By Drug Type (Small Molecule and Large Molecules); By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases and Other Applications); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030

AI for Drug Discovery Market By Offering (Software, Services);By Technology (Machine Learning and Other Technologies); By Drug Type (Small Molecule and Large Molecules); By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases and Other Applications); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030

Life Science Analytics Market: Market Segments: By Type (Reporting, Descriptive, Predictive and Prescriptive); By Application (Research and Development, Sales and Marketing, Regulatory Compliance, Supply Chain Analytics and Pharmacovigilance); By Delivery Model (On-demand and On-premises); By End-user (Medical Devices, Pharmaceutical, Biotechnology and Others); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Life Science Analytics Market: Market Segments: By Type (Reporting, Descriptive, Predictive and Prescriptive); By Application (Research and Development, Sales and Marketing, Regulatory Compliance, Supply Chain Analytics and Pharmacovigilance); By Delivery Model (On-demand and On-premises); By End-user (Medical Devices, Pharmaceutical, Biotechnology and Others); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Healthcare IT Integration Market: Market Segments: By Product & Service (Products and Services); By End-User (Hospitals, Laboratories, Clinics, Diagnostic Imaging Centers and Other); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Healthcare IT Integration Market: Market Segments: By Product & Service (Products and Services); By End-User (Hospitals, Laboratories, Clinics, Diagnostic Imaging Centers and Other); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Ambulatory EHR Market: Market Segments: By Delivery Mode (Cloud-based and On-premise); By Application (Practice Management, Patient Management, e-Prescribing, Referral Management, Population Health Management, Decision Support and Health Analytics); By End-User (Hospital-Owned Ambulatory Centers and Independent Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Ambulatory EHR Market: Market Segments: By Delivery Mode (Cloud-based and On-premise); By Application (Practice Management, Patient Management, e-Prescribing, Referral Management, Population Health Management, Decision Support and Health Analytics); By End-User (Hospital-Owned Ambulatory Centers and Independent Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030